News

Bottlenecks in the delivery of medicinal products to clinics

Bottlenecks in the delivery of medicinal products to clinics

Bottlenecks in the supply of pharmaceuticals - hospitals lack the right medication
12.11.2013

Germany's clinics complain about supply shortages of medicines. This emerges from the assessment report of the Deutsche Kranhakenhausgesellschaft (DKG).

Accordingly, the DKG surveyed 20 pharmacies that supply more than 140 clinics in Germany with medicines. On average, the hospital pharmacies were no longer able to provide around 20 drugs on time. In the same period of the previous year, an average of 25 drugs were reported as not available per month. This is a slight improvement, but in 39 percent of all cases no alternative preparation could be delivered. In comparison, this is clearer than in the previous year. The problems relate to all drug groups. If there are delivery bottlenecks with cytostatics (anti-cancer drugs), this is of course a particularly serious problem. With antibiotics, doctors would sometimes have to consider which patient needs the drug more urgently. According to the definition of the BfArM, a delivery bottleneck occurs when drugs and medical devices cannot be delivered for more than two weeks.

"We are very worried because the delivery bottlenecks also involve drugs for oncology and intensive care medicine," a DKG spokesman told the German Medical Association. As the pharmaceutical manufacturers have so far only reported delivery bottlenecks on a voluntary basis, hospitals are now demanding that a binding notification be made. For this purpose, a registration register was set up at the BfArM at the end of April. "Our urgent recommendation to politicians is to change the register management of drug shortages from voluntary to binding," said DKG chief executive Georg Baum. The reason for the bottlenecks is given by the pharmaceutical manufacturers' prompt production in Asia and low inventories. (fr)

Image: jokerbomber / pixelio.de

Author and source information

Video: TRACO 2017 - Clinical trials and Precision Medicine (October 2020).